Andrew Gallagher

Andrew has been developing healthcare products (Rx, OTC and consumer healthcare) from plants for over 14 years and has a deep understanding of the science behind Phynova’s products. He previously held business development, operations and R&D roles within Phynova, as well as business development role for the clinical research organisation Kendle (acquired by INC Research) and as biochemistry lecturer at the University of Natal (South Africa). Andrew holds an MSc (Biology) from the University of Natal, an MBA (Finance) awarded with Distinction from the University of Leicester, and is completing a PhD in Health Economics at Monash University. Andrew is based in Melbourne, Australia.